Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLPG0634 dose-ranging study with methotrexate in active rheumatoid arthritis
2011-005008-14Phase 2Completed
- Sponsor
- Galapagos NV
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of filgotinib in rheumatoid arthritis (RA) (5 arms), sponsored by Galapagos NV. Primary endpoint: ACR20 response at Week 4. Started Feb 2012; status: completed.
02
Drugs
filgotinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2011-005008-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005008-14.